Abstract
The Cell division cycle 7 (Cdc7) protein kinase is essential for DNA replication and maintenance of genome stability. We systematically explored thiazole-based compounds as inhibitors of Cdc7 kinase activity in cancer cells. Our studies resulted in the identification of a potent, selective Cdc7 inhibitor that decreased phosphorylation of the direct substrate MCM2 in vitro and in vivo, and inhibited DNA synthesis and cell viability in vitro.
Keywords:
Cdc7; DNA replication; Kinase inhibitor; MCM2; Thiazole.
Copyright © 2014 Elsevier Masson SAS. All rights reserved.
MeSH terms
-
Animals
-
Catalytic Domain
-
Cell Cycle Proteins / antagonists & inhibitors*
-
Cell Cycle Proteins / chemistry
-
Cell Cycle Proteins / metabolism
-
Cell Line, Tumor
-
Chemistry Techniques, Synthetic
-
Female
-
HCT116 Cells
-
Humans
-
Inhibitory Concentration 50
-
Male
-
Mice
-
Minichromosome Maintenance Complex Component 2 / metabolism
-
Molecular Docking Simulation
-
Phosphorylation / drug effects
-
Protein Kinase Inhibitors / chemical synthesis*
-
Protein Kinase Inhibitors / chemistry
-
Protein Kinase Inhibitors / metabolism
-
Protein Kinase Inhibitors / pharmacology*
-
Protein Serine-Threonine Kinases / antagonists & inhibitors*
-
Protein Serine-Threonine Kinases / chemistry
-
Protein Serine-Threonine Kinases / metabolism
-
Rats
-
Structure-Activity Relationship
-
Thiazoles / chemical synthesis*
-
Thiazoles / chemistry
-
Thiazoles / metabolism
-
Thiazoles / pharmacology*
-
Xenograft Model Antitumor Assays
Substances
-
Cell Cycle Proteins
-
Protein Kinase Inhibitors
-
Thiazoles
-
CDC7 protein, human
-
Protein Serine-Threonine Kinases
-
MCM2 protein, human
-
Minichromosome Maintenance Complex Component 2